Questioning the justification for a fourth SARS-CoV-2 vaccine.

Calderon-Margalit, Ronit; Strahilevitz, Jacob; Paltiel, Ora

Calderon-Margalit, Ronit; Strahilevitz, Jacob; Paltiel, Ora.

Affiliation

Calderon-Margalit R; Braun School of Public Health, Hadassah Medical Center, Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Strahilevitz J; Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: jstrahilevitz@hadassah.org.il.
Paltiel O; Braun School of Public Health, Hadassah Medical Center, Faculty of Medicine, Hebrew University, Jerusalem, Israel; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel.

Clin Microbiol Infect ; 28(7): 905-907, 2022 07.

Article in En | MEDLINE | ID: mdl-35339674

Subject(s)

COVID-19; Viral Vaccines; Antibodies, Viral; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Key words

Booster vaccine; COVID-19; SARS-CoV-2 vaccine; Vaccine adverse effect; Vaccine efficacy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Limits: Humans Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2022 Document type: Article Affiliation country: Israel Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google